Gene · 580
Papers4,139
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 4,139
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PARP Inhibitors: A New Horizon for Patients with Prostate Cancer. | Biomedicines | 2022 | 35740437 | PubTator, text mining | PubMed |
| Multigene Panel Testing in Turkish Hereditary Cancer Syndrome Patients. | Medeni Med J | 2022 | 35734982 | PubTator, text mining | PubMed |
| Clinical Benefits of Olaparib in Mexican Ovarian Cancer Patients With Founder Mutation BRCA1-Del ex9-12. | Front Genet | 2022 | 35734436 | PubTator, text mining | PubMed |
| Psychological and health behaviour outcomes following multi-gene panel testing for hereditary breast and ovarian cancer risk: a mini-review of the literature. | Hered Cancer Clin Pract | 2022 | 35733200 | PubTator, text mining | PubMed |
| An appraisal of genetic testing for prostate cancer susceptibility. | NPJ Precis Oncol | 2022 | 35732815 | PubTator, text mining | PubMed |
| The TIP60-ATM axis regulates replication fork stability in BRCA-deficient cells. | Oncogenesis | 2022 | 35717336 | PubTator, text mining | PubMed |
| Investigation of BRCAness associated miRNA-gene axes in breast cancer: cell-free miR-182-5p as a potential expression signature of BRCAness. | BMC Cancer | 2022 | 35715772 | PubTator, text mining | PubMed |
Spectrum of germline pathogenic variants using a targeted next generation sequencing panel and genotype-phenotype correlations in patients with suspected hereditary breast cancer at an academic medical centre in Pakistan. | Hered Cancer Clin Pract | 2022 | 35710434 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Expression and Prognostic Value of LMAN2 in HER2+ Breast Cancer. | J Immunol Res | 2022 | 35707004 | PubTator, text mining | PubMed |
| Pilot Study: PARP1 Imaging in Advanced Prostate Cancer. | Mol Imaging Biol | 2022 | 35701722 | PubTator, text mining | PubMed |
| Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis Inhibitors. | Target Oncol | 2022 | 35699834 | PubTator, text mining | PubMed |
| A field guide to the proteomics of post-translational modifications in DNA repair. | Proteomics | 2022 | 35695711 | PubTator, text mining | PubMed |
| Development and Validation of a Novel PPAR Signaling Pathway-Related Predictive Model to Predict Prognosis in Breast Cancer. | J Immunol Res | 2022 | 35692496 | PubTator, text mining | PubMed |
| Exploring the cellular landscape of circular RNAs using full-length single-cell RNA sequencing. | Nat Commun | 2022 | 35688820 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| Monoubiquitination in Homeostasis and Cancer. | Int J Mol Sci | 2022 | 35682605 | PubTator, text mining | PubMed |
| Structural and Functional Insights into GID/CTLH E3 Ligase Complexes. | Int J Mol Sci | 2022 | 35682545 | PubTator, text mining | PubMed |
| Insights into the Possible Molecular Mechanisms of Resistance to PARP Inhibitors. | Cancers (Basel) | 2022 | 35681784 | PubTator, text mining | PubMed |
| Are Mutation Carrier Patients Different from Non-Carrier Patients? Genetic, Pathology, and US Features of Patients with Breast Cancer. | Cancers (Basel) | 2022 | 35681739 | PubTator, text mining | PubMed |
| Risk-reducing surgery in unaffected individuals receiving cancer genetic testing in an integrated health care system. | Cancer | 2022 | 35679147 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/580/papers?page=53